A LESS ACIDIC HUMAN FOLLICLE-STIMULATING-HORMONE PREPARATION INDUCES TISSUE-TYPE PLASMINOGEN-ACTIVATOR ENZYME-ACTIVITY EARLIER THAN A PREDOMINANTLY ACIDIC ANALOG IN PHENOBARBITAL-BLOCKED PRO-ESTROUS RATS
C. Timossi et al., A LESS ACIDIC HUMAN FOLLICLE-STIMULATING-HORMONE PREPARATION INDUCES TISSUE-TYPE PLASMINOGEN-ACTIVATOR ENZYME-ACTIVITY EARLIER THAN A PREDOMINANTLY ACIDIC ANALOG IN PHENOBARBITAL-BLOCKED PRO-ESTROUS RATS, Molecular human reproduction (Print), 4(11), 1998, pp. 1032-1038
Follicle-stimulating hormone (FSH) exists in multiple molecular forms.
In both experimental animals and in humans the production and secreti
on of less acidic, short-lived FSH glycoforms significantly increase d
uring the peri-ovulatory period. To gain further insights on the physi
ological role of these FSH variants, we analysed the ability of two FS
H compounds, recombinant FSH (rFSH) and purified FSH from urinary orig
in (uFSH), (less acidic and acidic pattern of FSH charge isoform distr
ibutors respectively) to induce ovarian tissue-type plasminogen activa
tor (tPA) enzyme activity in vivo. FSH produced by Chinese hamster ova
ry cells and highly purified uFSH were injected at 15:00 h on the pro-
oestrous day into phenobarbital-blocked rats and the ovaries were anal
ysed for tPA enzyme activity and tPA mRNA concentrations at different
times after FSH injection. Induction of tPA enzyme activity by uFSH an
d rFSH showed distinct dynamics depending on the particular preparatio
n administered. In animals treated with uFSH, maximum tPA enzyme activ
ity was detected at 20:00 h, and maximum tPA mRNA concentrations were
detected at 17:00 h. tPA enzyme activity induction by rFSH was at the
maximum at 17:00 h, and maximum tPA mRNA concentration was at 16:00 h
(P < 0.05 for uFSH versus rFSH). All animals in the uFSH- and rFSH-tre
ated groups and none in phenobarbital-blocked, saline-treated controls
ovulated. No significant differences were present in the number of ov
a shed by rats treated with uFSH or rFSH and spontaneously ovulating r
ats (10.7 +/- 1.7, 10.0 +/- 2.6 and 11.3 +/- 1.6 respectively). These
data indicate that the increased biological activity exhibited by less
acidic FSH glycovariants at the target cell level may compensate for
the drawback imposed by their relatively short plasma half-life.